Gilead Sciences (GILD) PT Raised to $115 at Oppenheimer
Tweet Send to a Friend
Oppenheimer analyst Hartaj Singh raised the price target on Gilead Sciences (NASDAQ: GILD) to $115.00 (from $105.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
